Review article on hemodialysis and its complications

Authors

  • Manav Singh Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760
  • S.P. Srinivas Nayak Assistant Professor, Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760.
  • Preeti Tiwari Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760
  • Sahil Shaikh Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760
  • Vaidik Gautam Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760
  • Prajwal Waman Ghatol Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760

DOI:

https://doi.org/10.22270/ajprd.v11i2.1236

Keywords:

Hemodialysis, End stage renal disease, Complications, Hypotension, Anaemia

Abstract

The ability to evaluate outcomes among patients with ESRD increased dramatically after 1988, when the United States Renal Data System (USRDS) was established to record and issue reports that would track mortality and morbidity and determine factors affecting clinical outcomes. Hemodialysis is now substantially safer than it was initially, and deaths directly related to the dialysis procedure are rare. Improved dialysate delivery systems, more reliable monitoring devices, and automated safety mechanisms have reduced the risk of complications. Other technical improvements include the standard use of the more physiologic bicarbonate-based dialysate, better water-quality standards, volumetric ultrafiltration controls, and computer-controlled sodium and potassium modeling. Several in-line devices now allow dynamic monitoring of the rate of blood flow through the vascular access, changes in the hematocrit, and changes in the electrical conductivity of the dialysate, but the complication related to dialysis has not decreased as a result complication related to dialysis is persistent.

 

Downloads

Download data is not yet available.

Author Biographies

Manav Singh, Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760

Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760

S.P. Srinivas Nayak, Assistant Professor, Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760.

Assistant Professor, Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760.

Preeti Tiwari, Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760

Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760

Sahil Shaikh, Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760

Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760

Vaidik Gautam, Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760

Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760

Prajwal Waman Ghatol, Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760

Department of Pharmacy Practice, Parul Institute of Pharmacy and Research. Parul University, Vadodara, Gujarat, India, 391760

References

1. B H Scribner Rbjecrhjmb. The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report. Trans Am Soc Artif Intern Organs . 1960 Apr 6;
2. Himmelfarb J, Alp Ikizler T. Hemodialysis. Vol. 19, n engl j med. 2010.
3. Charles C, Ferris AH. Chronic Kidney Disease. Vol. 47, Primary Care - Clinics in Office Practice. W.B. Saunders; 2020. p. 585–95.
4. Sharma . Standard Treatment Guidelines - A Manual Of Medical Therapeutics, 4/e pg. 269-270 .https://ebooks.lwwindia.co.in/pdfreader/standard-treatment-guidelines-manual-medical-therapeutics-4e
5. Nayak et al, Autosomal Dominant Polycystic Kidney Disease And New Treatment Approaches wjpmr, Vol 6, Issue 11, 2020
6. Elliott DA. Hemodialysis. Clin Tech Small AnimPract. 2000; 15[3]:136–48.
7. Meyer TW, Hostetter TH. MEDICAL PROGRESS Uremia [Internet]. Vol. 357, N Engl J Med. 2007. Available from: www.nejm.org
8. Rathi M, Pinnamaneni VST, Sakhuja V. Non-imaging assisted insertion of un-cuffed, non-tunneled internal jugular venous catheters for hemodialysis: Safety and utility in modern day world. Biomed J. 2016 Aug 1;39[4]:283–8.
9. Charles C, Ferris AH. Chronic Kidney Disease. Vol. 47, Primary Care - Clinics in Office Practice. W.B. Saunders; 2020. p. 585–95.
10. Raja SM, Seyoum Y. Intradialytic complications among patients on twice-weekly maintenance hemodialysis: An experience from a hemodialysis center in Eritrea. BMC Nephrol. 2020 May 5; 21[1].
11. Ishibe S, Peixoto AJ. Methods of Assessment of Volume Status and Intercompartmental Fluid Shifts in Hemodialysis Patients: Implications in Clinical Practice. Vol. 17, Seminars in Dialysis.
12. Reeves PB, McCausland FR. Mechanisms, clinical implications, and treatment of intradialytic hypotension. Vol. 13, Clinical Journal of the American Society of Nephrology. American Society of Nephrology; 2018. p. 1297–303.
13. Atar I, Konaş D, Açikel S, Külah E, Atar A, Bozbaş H, et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol. 2006 Jan 4; 106[1]:47–51.
14. Abuelo JG. Treatment of Severe Hyperkalemia: Confronting 4 Fallacies. Vol. 3, Kidney International Reports. Elsevier Inc; 2018. p. 47–55.
15. Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clinical Journal of the American Society of Nephrology. 2007 Sep; 2[5]:999–1007.
16. Sterns RH. Treatment of severe hyponatremia. Clinical Journal of the American Society of Nephrology. 2018 Apr 6; 13[4]:641–9.
17. Hecking M, Karaboyas A, Saran R, Sen A, Hörl WH, Pisoni RL, et al. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: The Dialysis Outcomes and Practice Patterns Study [DOPPS]. American Journal of Kidney Diseases. 2012 Feb; 59[2]:238–48.
18. Saha M, Allon M. Diagnosis, treatment, and prevention of hemodialysis emergencies. Vol. 12, Clinical Journal of the American Society of Nephrology. American Society of Nephrology; 2017. p. 357–69.
19. P.Subhashini, K.R. Sangamithra, K Thirumala Naik, & S P Srinivas Nayak. [2021]; Therapeutic Approaches of Hyperkalemia Induced By Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. SRJ Clin & Med Sci. 1[3] 1-4.
20. Hyodo T, Taira T, Takemura T, Yamamoto S, Tsuchida M, Yoshida K, et al. Immediate effect of Shakuyaku-kanzo-to on muscle cramp in hemodialysis patients. Nephron Clin Pract. 2006 ;104[1].
21. M E De Broe. Haemodialysis-induced hypoxaemia. Nephrol Dial Transplant . 1994;
22. Fried W. Hematologic complications of chronic renal failure. Medical Clinics of North America. 1978;62[6]:1363–79.
23. Dr. S. P. Srinivas Nayak, SyedaMaimoona Maqsood, Azgari Begum, Sania Mehveen, Lubna Muzaffar Hussain, Evaluating Risk Of Heart Failure With Erythropoietin In Chronic Anemia, Wjppr, Volume 9, Issue 10, 770-787
24. Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J, et al. Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease. BMC Nephrol. 2017 Nov 30;18[1].
25. Davenport A. Core Curriculum Intradialytic complications during hemodialysis.
26. Brunet P, Berland Y. Water quality and complications of haemodialysis. Nephrol Dial Transplant, 2000 May;15(5):578-80. doi: 10.1093/ndt/15.5.578. PMID: 10809794.
27. Schwanke AA, Danski MTR, Pontes L, Kusma SZ, Lind J. Central venous catheter for hemodialysis: incidence of infection and risk factors. Rev Bras Enferm. 2018 May 1; 71[3]:1115–21.
28. Beathard GA, Welch BR, Maidment HJ. Mechanical thrombolysis for the treatment of thrombosed hemodialysis access grafts. Radiology. 1996 Sep;200(3):711-6. doi: 10.1148/radiology.200.3.8756920. PMID: 8756920.
29. Mohammed Ashfaq, Syed Jaffer, Abdul Mushtaq Mohammed, ShaistaSumayya, SP Srinivas Nayak. Antiplatelet and antithrombotic therapy in diabetic patients recent updates. Int J Appl Res 2021;7[3]:76-79.
30. Beathard GA, Litchfield T; Physician Operators Forum of RMS Lifeline, Inc. Effectiveness and safety of dialysis vascular access procedures performed by interventional nephrologists. Kidney Int. 2004 Oct;66(4):1622-32. doi: 10.1111/j.1523-1755.2004.00928.x. PMID: 15458459.
31. Masud A, Costanzo EJ, Zuckerman R, Asif A. The Complications of Vascular Access in Hemodialysis. Semin ThrombHemost. 2018 Feb 1;44[1]:57–9.
32. Syed Irfan Ali Ahmed, S.P.SrinivasNayak, K.R.Madhuri, B.Jyothi, K.Umamaheshwar Rao, V.Kiranmayi, V.Siva Kumar a study on pharmacological management of mineral bone disease in chronic kidney disease patients in a tertiary care hospital, ijsr, vol.9 no.11 nov 2018, 201-206.
33. Dr. S P Srinivas Nayak, et al, The Nutrition Therapy In Diabetic Patients: A Review, International Journal of Research and Analytical Reviews [IJRAR], E-ISSN 2348-1269, P- ISSN 2349-5138, Volume.7, Issue 3, Page No pp.665-676, September 2020
34. Traeger J. Daily hemodialysis and nutrition. Journal of Renal Nutrition. 2000 Oct;10[4]:169.

Published

2023-04-15

How to Cite

Singh, M., Srinivas Nayak, S., Tiwari, P., Shaikh, S., Gautam, V., & Waman Ghatol, P. (2023). Review article on hemodialysis and its complications. Asian Journal of Pharmaceutical Research and Development, 11(2), 60–64. https://doi.org/10.22270/ajprd.v11i2.1236